Journal Home
Search for

Volume 17, Issue 7, Pages 519-526 (June 2010)


View previous. 7 of 11 View next.

Ardipusilloside I purified from Ardisia pusilla competitively binds VEGFR and induces apoptosis in NCI-H460 cells

Yanmin Zhanga, Youle Qub, Jie Zhanga, Xiaojuan WangcCorresponding Author Informationemail address

published online 10 February 2010.

Abstract 

The present study was to evaluate the effects of Ardipusilloside I isolated from Ardisia pusilla on the growth, vascular endothelial growth factor receptor (VEGFR) expression and apoptosis of NCI-H460 cell line by MTT, ELISA and flow cytometer, respectively. The docking assay between Ardipusilloside I and VEGFR was studied by Sybyl/Sketch module. The change of microstructure was observed by transmission electron microscope (TEM). DNA fragmentation was visualized by agarose gel electrophoresis. The protein expression of Bax and Bcl-2 was detected by immunohistochemistry (IHC). A series of changes were observed in NCI-H460 cell treated by Ardipusilloside I, including microstructure, DNA fragmentation, protein expression of VEGFR, Bax and Bcl-2. The results showed Ardipusilloside I had a good docking with VEGFR and could inhibit growth and induce apoptosis of NCI-H460 cell in a dose-dependent manner. Cell cycle was significantly stopped at the G1 phase. Under electronic microscope, the morphology of NCI-H460 cell treated with Ardipusilloside I showed nuclear karyopycnosis, chromatin agglutination and typical apoptotic body. VEGFR and Bcl-2 expression were decreased and Bax expression was increased. In conclusion, all these results demonstrate that Ardipusilloside I has a good docking with VEGFR and has an inhibitory effect on growth of NCI-H460 cell and can induce its apoptosis.

a School of Medicine, Xi'an Jiaotong University, Xi'an 710061, PR China

b School of Food and Pharmcy, Zhejiang Ocean University, Zhoushan 316004, PR China

c Department of Pharmaceutical Preparation, School of Stomatology, Fourth Military Medical University, Xi'an 710032, PR China

Corresponding Author InformationCorresponding author. Tel.: +862984776189;

PII: S0944-7113(09)00227-X

doi:10.1016/j.phymed.2009.09.001


View previous. 7 of 11 View next.